Qube Research & Technologies LTD Fibrogen Inc Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Fibrogen Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 34,976 shares of FGEN stock, worth $10,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,976
Previous 64,557
45.82%
Holding current value
$10,842
Previous $25,000
28.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding FGEN
# of Institutions
79Shares Held
37.4MCall Options Held
351KPut Options Held
105K-
Armistice Capital, LLC New York, NY6.8MShares$2.11 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$1.82 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA4.62MShares$1.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.21 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$746,9910.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $29.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...